Skandinaviska Enskilda Banken AB publ Purchases 958 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Skandinaviska Enskilda Banken AB publ boosted its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 6.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 16,615 shares of the biotechnology company's stock after purchasing an additional 958 shares during the period. Skandinaviska Enskilda Banken AB publ's holdings in Axon Enterprise were worth $10,040,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the stock. Asset Dedication LLC raised its stake in shares of Axon Enterprise by 11.3% in the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock worth $106,000 after acquiring an additional 18 shares during the last quarter. Bleakley Financial Group LLC raised its stake in shares of Axon Enterprise by 1.3% in the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock worth $908,000 after acquiring an additional 20 shares during the last quarter. Venturi Wealth Management LLC raised its stake in shares of Axon Enterprise by 2.7% during the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock worth $477,000 after buying an additional 21 shares during the last quarter. Insigneo Advisory Services LLC raised its stake in shares of Axon Enterprise by 1.4% during the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock worth $627,000 after buying an additional 22 shares during the last quarter. Finally, Menard Financial Group LLC raised its stake in shares of Axon Enterprise by 0.8% during the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company's stock worth $1,204,000 after buying an additional 24 shares during the last quarter. 79.08% of the stock is owned by institutional investors.

Remove Ads

Axon Enterprise Stock Up 5.2 %

Shares of Axon Enterprise stock traded up $28.12 on Wednesday, hitting $568.11. The company had a trading volume of 575,915 shares, compared to its average volume of 852,230. The firm has a market capitalization of $43.53 billion, a P/E ratio of 146.80, a P/E/G ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The stock has a 50-day moving average of $592.66 and a 200-day moving average of $539.27.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on AXON. Craig Hallum downgraded shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. JMP Securities reissued an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. Northcoast Research cut shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Finally, Needham & Company LLC restated a "buy" rating and set a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $604.67.

Insider Activity

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business's stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares of the company's stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Jeri Williams sold 307 shares of the business's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 1,792 shares of company stock worth $1,087,843 over the last quarter. 5.70% of the stock is currently owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.